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EDITORIAl
The articles published in this issue of the journal Rad – Medical Sciences are 
contributions by invited speakers at the 6th symposium DEVELOPMENTAL BIO-
lOGY OF PlATElETS, THROMBOCYTOPENIA AND MYElOPROlIFERATIVE 
NEOPLASMS, organized by the Department of Clinical and Transplantation Immu-
nology and Molecular Medicine of the Croatian Academy of Sciences and Arts in 
Rijeka. The meeting was held in Rijeka on 12 March 2015. Co-organizers were the 
Clinical Hospital Centre in Rijeka, the Medical Faculty of the University of Rijeka, 
and the Croatian Medical Association – Branch Office Rijeka. The aim of the mee-
ting was to highlight several recent breakthroughs in the field of the thrombopoiesis 
by promoting the interdisciplinary approach in the range from basic sciences to 
clinical practice and international collaboration. New approaches in the education 
of Pathophysiology under the message Education Today for Health Tomorrow were 
addressed as well. 
In order to upgrade the understanding of disease phenomena, Professor Z. Ko-
vac from Zagreb has developed the concept of etiopathogenetic clusters (EPC). The 
way in which he defined and elaborated this concept is a new and unique approach 
in the field of basic and clinical medicine, and has already attracted broad internati-
onal recognition. Etiopathogenetic clusters were defined as a common tendency of 
heterogeneous pathological pathways to form common crossing points of reactivity. 
The EPCs integrate multiple inputs and look like natural integrators of human body 
response. This concept can help preserve the physicians’ approach to the whole 
body as the referent concept and orientation in medicine despite the progressive 
compartmentalization into narrow fields of interest (specializations, sub-specializa-
tions). They may use algorhythms and EPCs as methodological attempts to fuse the 
visions of and insights into the two major cognitive pillars – clinical medicine and 
biomedical research – for the integrative physiology of human body diseases/disor-
ders. Thrombocytopenia, bleeding diathesis and hypercoagulability are outlined as 
individual EPC. 
Dr. Sc. A. Begonja Jurak from Rijeka highlighted several new basic mechanisms 
in megakaryopoiesis and thrombopoiesis. These are series of complex events thro-
ugh the remodelling of megakaryocyte cytoskeleton, the formation of proplatelets, 
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and the final maturation of platelets. Abnormalities in these processes may lead to 
clinically recognized disorders. Dr. Sc. D. Baković from Split stressed the importan-
ce of the so-called large platelets (platelets with a high mean platelet volume – MPV) 
as recognized prothrombotic factors. Large platelets have a higher prothrombotic 
potential and MPV – as the commonly used measure of platelet size, it is a simple 
and easy method to assess the platelet function accurately. 
Clinical aspects of thrombocytopenia were highlighted in all periods of life. 
Thrombocytopenia is commonly found in pregnancy; it can significantly influence 
both the mother and the fetus/newborn. Professor A. Duletić-Načinović from Rijeka 
discussed the diagnosis and management of various causes of thrombocytopenia in 
pregnancy. Professor J. Roganović from Rijeka presented cases, clinical and therape-
utic aspects of the immune childhood thrombocytopenia. This is usually a benign 
disorder, most common in young children, following a viral infection, and usually 
with spontaneous recovery. Recent guidelines recommend careful observation as 
appropriate for paediatric patients with mild bleeding or none, regardless of the 
platelet count. Professor N. Suvajdžić from Belgrade, Serbia discussed a new con-
cept of Primary immune thrombocytopenia (ITP) in adults, which is an acquired 
autoimmune disorder characterized by isolated thrombocytopenia in the absence of 
known causes. Recently (in 2009), the international consensus on terminology, de-
finitions and outcome criteria was reached for ITP. Professor M. Todorović-Tirnanić 
from Belgrade, Serbia presented the results of twenty-four years of experience with 
the method of autologous platelet labelling with Indium-111 oxinate and labelled 
platelets lifespan, production and sequestration site determination. Based on the 
labelled platelets sequestration site determination, it was possible to predict the effi-
cacy of splenectomy in ITP patients. 
In the group of papers focussed on the treatment of thrombocytopenia, Dr. Sc. 
I. Jukić from Zagreb discussed the clinical relevance of antiplatelet antibodies, and 
the relevance of the serological methods and recently developed molecular biologi-
cal methods that have enabled a more accurate determination of platelet antigens, 
and improved the evaluation of the role of these antigens in many thrombocytope-
nic syndromes, associations with susceptibility to diseases, and the outcome of allo-
geneic bone marrow and solid organ transplantation. Professor S. Balen from Rijeka 
gave an excellent contribution to the understanding of the organization, activities 
and function of the clinical transfusion centre, and gave a complete view on many 
debates and controversies regarding the advantage of giving prophylactic compared 
to therapeutic transfusion, the platelet collection method, and the optimal platelet 
dose to be transfused. During the meeting, Professor P. Černelč from Ljubljana, Slo-
venia presented results of new achievements in the therapy of both primary immu-
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entities, by monoclonal anti CD20 antibody rituximab and drugs that are agonists 
of thrombopoietic receptor (TPO-RA), stimulating the bone marrow production of 
megakaryocytes that consequently increase the thrombocyte number in the pe-
ripheral blood. Professor D. Pulanić from Zagreb stressed the issue of the chronic 
form of the reaction of transplanted cells (allogeneic haematopoietic cells) against 
the host (Graft versus Host Disease – GvHD), which is frequently accompanied by 
thrombocytopenia and other coagulation disorders; this is usually an unfavourable 
prognostic sign for successful transplant survival. 
Essential thrombocytemia is a state opposite to thrombocytopenia and belongs 
to myeloproliferative neoplastic disorders. Professor R. Kušec from Zagreb highli-
ghted genetic aspects of the disease, since in the last ten years major breakthroughs 
were made in the diagnostics of molecular genetic defects responsible for the deve-
lopment of essential thrombocytemia. Professor T. Valković from Rijeka described 
all the major aspects of essential thrombocytemia, which is a clonal Ph-negative 
myeloproliferative neoplasm characterized –besides by thrombocytosis – by bone 
marrow megakaryocytic hyperplasia and a tendency to develop vascular complica-
tions as well. 
The articles presented in this issue of Rad – Medical Sciences, in addition to the 
discussions and presentations held during the symposium, encompass the thematic 
range tackled at the symposium, and relate to the whole cycle of the developmen-
tal biology of megakaryocytes, the production of thrombocytes, relatively frequ-
ent thrombocytopenias, myeloproliferative neoplasms (essential thrombocytemia), 
and the treatment of these disorders. I hope the texts will be of value to specialists, 
experts and medical students.
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